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TO THE EDITOR
The use of human skin grafts in severe
combined immune deficiency (SCID)
mice has been a powerful research tool
for delineating the pathogenesis of
psoriasis. The initial model for the
induction of psoriasis consisted of hu-
man non-lesional psoriatic skin grafted
to SCID mice, followed by the injection
of human lymphocytes activated with
staphylococcal superantigens (Wrone-
Smith and Nickoloff, 1996; Nickoloff,
2000a; Boehncke, 2001). This human
skin graft/SCID mouse model for psor-
iasis has also been used to test various
therapeutic modalities, such as corti-
costeroid, cyclosporine and anti-
CD11a mAb (Boehncke et al., 1999;
Dam et al., 1999; Zeigler et al., 2001).
Furthermore, natural killer (NK) cells
and T cells with NK receptors (CD94,
CD161) can induce psoriasis in human
skin grafts on SCID mice (Nickoloff
et al., 2000b; Gilhar et al., 2002, 2006).
Table 1. Sequences of primers










GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KRT10, keratin 10; KRT14, keratin 14; PCNA,
proliferating cell nuclear antigen; RPLP0, ribosomal protein large P0; TBP, TATA-binding protein;
TUBA1B, a-tubulin1B.
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The human skin graft/SCID mouse
system cannot serve as a tool for
detecting the initial role of various
mediators in psoriasis and graft-versus-
host disease (GVHD). Studies of signal-
ing pathways for disease induction are
restricted to observation or intervention
with drugs or monoclonal antibodies.
What is needed is a human system that
can make use of molecular biology
tools to study the role of the activation
pathways. Such potential tools include
anti-sense, siRNA, and dominant-
negative genes. The introduction of genes
into intact skin grafts with viral vectors
is problematic due to the low transfer
efficiency. It would thus be preferable
to make use of human skin equivalent
comprised of cultured keratinocytes
and fibroblasts. Cultured keratinocytes
could be transduced in vitro and
selected for transgene expression before
the formation of the skin equivalent.
Human skin equivalents comprised
of spontaneously sorted adult human
keratinocytes and fibroblasts have al-
ready been developed by Wang et al.
(2000). The most significant and novel
advance will be to induce inflammatory
skin diseases, psoriasis, and GVHD in
skin equivalents by injecting various
factors such as activated NK cells
supposedly involved in the pathogen-
esis of these conditions.
Thus, the goal of this study is using,
to our knowledge a previously unre-
ported skin equivalent technique to
develop models of psoriasis and
GVHD. Human keratinocytes and fi-
broblasts were obtained from 6mm
punch skin biopsies of subjects, follow-
ing informed consent and IRB approval
and the study was performed in adher-
ence with the Declaration of Helsinki
Principles.
Biopsies were obtained from adults
having plaque psoriasis as well as
normal controls. Biopsy material was
treated overnight with Dispase II
(2.5mgml1 in DME) to separate the
epidermis from the dermis. The next
day, trypsin (0.01% in phosphate-
buffered saline) was used to obtain a
single-cell suspension of keratinocytes
from the epidermis. Fibroblasts were
obtained from the dermis after incuba-
tion in collagenase followed by trypsi-
nization, and were then placed into the
cell pellet. Keratinocytes were plated
onto plastic tissue culture plates and
cocultured with g-irradiated 3T3 mouse
fibroblasts in a 3:1 mixture of DME plus
F-12 and media. Fibroblasts were
grown in DME plus 10% fetal bovine
serum and penicillin/streptomycin
(100Uml1 each). Cells were cultured
at 37 1C with 7% CO2. Approximately
8-week-old CB-17/Icr.Cg-Prkdcscid
Lystbg/Crl (beige SCID) male mice
(Charles River, Wilmington, MA) were
used in this study. The left dorsum hair
was clipped and a full-thickness,
10mm diameter incision was made to
the left of the spine. Two-piece silicone
culture chambers were inserted into the
incision (CRD culture chambers, Re-
nner, Darmstadt, Germany). The cell
pellet (4106 keratinocytes and
8106 fibroblasts) was resuspended
and placed in the chamber through a
3mm hole at the top. The chambers
were removed on day 7.
Three sets of experiments were
performed. The first one involved four
mice and was carried out to determine
that our model indeed works (Figure 1).
The morphological analysis that had
been performed 4 weeks following the
engraftment revealed good epidermal
differentiation with a well-formed basal
cell layer, as well as a stratum corneum
with orthokeratosis (Figure 2a). Immuno-
histochemical staining showed positive
expression of involucrin in the supra-
basal layer of the epidermis, demon-
strating both appropriate differentiation
and the human origin of the epidermis.
Furthermore, staining with human anti-
HLA-A, B, C (W6/32) confirmed the
human origin of both epidermis and
dermis (data not shown).
The second set of experiments (eight
mice) was carried out to establish the
psoriatic mouse model. Culture of cells
with NK activity was prepared as
previously described (Gilhar et al.,
2002). NK cells (20 106) were in-
jected intradermally into 0.2ml media
containing IL2 under the skin equiva-
lents 6 weeks after grafting (four mice).
Control skin equivalents were injected
with 0.1ml of RPMI 1640 media (four
mice). Skin equivalents were harvested
for analysis 3 weeks later (9 weeks after
grafting). NK-cell injection resulted in a
psoriatic feature, as was observed in the
standard human skin graft/SCID mouse
system following the injection of NK
cells (Gilhar et al., 2002; Figure 2b–d).
Mean epidermal thickness increased
significantly in the NK-cell-injected
grafts, as shown by the t-test
(Po0.01). The human origin of the skin
equivalent was confirmed by staining
with anti-HLA-A, B, C (W6/32). Positive
expression of HLA-DR was observed by
both epidermal cells (Figure 2e) and
lymphocyte infiltrates along the upper
part of the dermis, indicating an im-
mune activation of these populations.
Involucrin expression was noted along
the psoriasiform epidermis (Figure 2f ).
The human skin graft/SCID mouse
model is also used to study the
mechanism of GVHD (Moulton et al.,
1999). Thus, the injection of human T
cells into the skin equivalent can also
be used for developing an advanced
model for GVHD. In total, 15 mice with
skin equivalent grafts of approximately
8mm were injected with human lym-
phocytes activated in mixed lympho-
cyte culture. The injection of allogeneic
T-cells sensitized against skin major
histocompatibility complex of the skin
equivalent resulted in a characteristic
histological feature of GVHD. These
data demonstrate the feasibility of using
spontaneously sorted skin equivalents





















Figure 1. Schema of the formation of the human skin equivalent model.
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Although the standard human skin
graft/SCID mouse model still has some
advantages (Table 1), this previously
unreported research method of using
a skin equivalent, to our knowledge,
has the potential of enhancing our
understanding of the pathognesis of
psoriasis, GVHD, and other inflamma-
tory skin diseases, and may help in
developing new therapies for various
skin disorders.
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Figure 2. Human skin equivalent. (a) Normal histology. (b) Human skin equivalent after autologous
NK cells injection–the epidermis shows marked psoriasiform hyperplasia and focal hypogranulosis.
There is tortuosity of blood vessels in the dermal papillae along with a mononuclear cell infiltrate.
(c) Parakeratosis and hypogranulosis with marked psoriasiform hyperplasia and dilation of blood
vessels and mononuclear cells in the dermal papillae. (d) A tortuous dilated blood vessel in a dermal
papilla. Positive HLA-DR expression by epidermal cells (e) and involucrin expression throughout the
hyperplastic epidermis (f). Bar¼ 100mm.
Table 1. Comparison between the human skin equivalent model and the standard human skin graft/SCID mouse
model
Human Skin Equivalent Model Standard Human Skin Graft/SCID Mouse Model
Advantages Disadvantages Advantages Disadvantages
1) Only 6mm punch skin biopsies
are required.
2) Allows the use of molecular
biology tools for the study of
signaling pathways in
inflammatory diseases.
1) Grafts are smaller (6–8mm).
2) Formation is more complicated.
3) Much less effective for evaluating
the effect of therapeutic agents.
1) Is currently the best model for
testing the role of T cells in psoriasis
(Gudjonsson et al. (2007)).
2) Has been used to test various
therapies.
1) Establishing the model requires
large keratome sheets.
2) The grafting must be performed
quickly.
3) Introducing or silencing the genes
is required.
SCID, severe combined immune deficiency.
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TO THE EDITOR
Keratitis, ichthyosis, and deafness (KID)
syndrome (OMIM #148210) is a rare
autosomal disorder associating vascu-
larizing keratitis with hyperkeratotic
skin lesions and profound hearing loss.
It is caused by dominant mutations in
the gene GJB2 (OMIM *121011) en-
coding connexin-26 or, more rarely, in
GJB6 (OMIM *604418) encoding con-
nexin-30 (Jan et al, 2004). Connexin-26
is a protein of gap junctions in epithe-
lia, notably of the corneal limbus, the
epidermis, sweat glands and ducts, hair
follicles, and the cochlea. Most cases
are sporadic and arise from a recurrent
missense mutation, c.148G4A (p.As-
p50Asn) (Richard, 2005). We report a
Figure 1. Clinical presentation of the patient and his mother. (a) The proband at birth, showing generalized erythema and scaling, and the absence of scalp hair,
eyebrows, and eyelashes. (b) The proband aged 27 months, showing opaque corneas, total alopecia, and generalized verrucous plaques especially prominent
on the scalp and face. (c and d) Bilateral hyperkeratotic and hyperpigmented lesions along the Blaschko lines on the mother’s chest, shoulders, and back.
Abbreviations: KID, Keratitis-Ichthyosis-Deafness; OMIM, Online Mendelian Inheritance in Man
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